{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T22:25:32Z","timestamp":1758407132080,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cyst infection is a prevalent complication in autosomal dominant polycystic kidney disease (ADPKD) patients, however therapeutic and diagnostic approaches towards this condition remain unclear. The confirmation of a likely episode of cyst infection by isolating the pathogenic microorganism in a clinical scenario is possible only in the minority of cases. The available antimicrobial treatment guidelines, therefore, might not be appropriate to some patients.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe two unique cases of kidney cyst infection by <jats:italic>Candida albicans,<\/jats:italic> a condition that has not been previously described in literature. Both cases presented clear risk factors for <jats:italic>Candida<\/jats:italic> spp. infection. However, since there was no initial indication of cyst aspiration and culture, antifungal therapy was not immediately started and empirical treatment was initiated as recommended by the current guidelines. Antifungal treatment was instituted in both cases along the clinical course, according to their specificities.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our report highlights the possibility of <jats:italic>Candida<\/jats:italic> spp. cyst infection. Failure of clinical improvement with antibiotics should raise the suspicion of a fungal infection. Identification of infected cysts should be pursued in such cases, particularly with PET-CT, and when technically possible followed by cyst aspiration and culture to guide treatment. Risk factors for this condition, such as <jats:italic>Candida<\/jats:italic> spp. colonization, previous antimicrobial therapy, hemodialysis, necrotizing pancreatitis, gastrointestinal\/hepatobiliary surgical procedure, central venous catheter, total parenteral nutrition, diabetes mellitus and immunodeficiency (neutropenia &lt;\u2009500 neutrophils\/mL, hematologic malignancy, chemotherapy, immunosuppressant drugs), should be also considered accepted criteria for empirical antifungal therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4444-y","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:44:43Z","timestamp":1572468283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Two cases of fungal cyst infection in ADPKD: is this really a rare complication?"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-5419","authenticated-orcid":false,"given":"Laura","family":"Onuchic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Augusto Hamamoto","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Precil Diego Miranda","family":"de Menezes Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Eduardo Pedroso","family":"Balbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Abel","family":"Portela-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Trani","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elieser Hitoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreia","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cl\u00e1udia Stockler","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"de Abreu Testagrossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Renato","family":"Chocair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Fernando","family":"Onuchic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"issue":"5","key":"4444_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","volume":"67","author":"FT Chebib","year":"2016","unstructured":"Chebib FT, Torres VE. Autosomal dominant polycystic kidney disease: Core curriculum 2016. Am J Kidney Dis. 2016;67(5):792\u2013810.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"4444_CR2","first-page":"1356","volume":"32","author":"CJ Willey","year":"2017","unstructured":"Willey CJ, Blais JD, Hall AK, et al. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant. 2017;32(8):1356\u201363.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4444_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman AB, Devuyst O, Eckardt KU, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015;88(1):17\u201327.","journal-title":"Kidney Int"},{"issue":"5","key":"4444_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/MNM.0000000000000466","volume":"37","author":"HW Kwona","year":"2016","unstructured":"Kwona HW, Lee HY, Hwang YH, et al. Diagnostic performance of 18F-FDG-labeled white blood cell PET\/CT for cyst infection in patients with autosomal dominant polycystic kidney disease: a prospective study. Nucl Med Commun. 2016;37(5):493\u20138.","journal-title":"Nucl Med Commun"},{"issue":"4","key":"4444_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/0002-9343(87)90005-2","volume":"82","author":"SJ Schwab","year":"1987","unstructured":"Schwab SJ, Bander SJ, Klahr S, et al. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987;82(4):714\u20138.","journal-title":"Am J Med"},{"issue":"5","key":"4444_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/ndt\/gfu227","volume":"30","author":"MA Lantinga","year":"2015","unstructured":"Lantinga MA, Drenth JPH, Gevers TJG. Diagnostic criteria in renal and hepatic cyst infection. Nephrol Dial Transplant. 2015;30(5):744\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4444_CR7","first-page":"144","volume":"32","author":"MA Lantinga","year":"2017","unstructured":"Lantinga MA, Casteleijn NF, Geudens A, et al. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review. Nephrol Dial Transplant. 2017;32(1):144\u201350.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"4444_CR8","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1093\/ndt\/gfs352","volume":"27","author":"F Jouret","year":"2012","unstructured":"Jouret F, Lhommel R. Devuyst. O, et al. diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant. 2012;27(10):3746\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"4444_CR9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s10096-015-2361-6","volume":"34","author":"T Suwabe","year":"2015","unstructured":"Suwabe T, Araoka H, Ubara Y, et al. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics. Eur J Clin Microbiol Infect Dis. 2015;34(7):1369\u201379.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"4444_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1590\/1414-431X20143584","volume":"47","author":"BEP Balbo","year":"2014","unstructured":"Balbo BEP, Sapienza MT, Ono CR, et al. Cyst infection in hospital-admitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volume. Braz J Med Biol Res. 2014;47(7):584\u201393.","journal-title":"Braz J Med Biol Res"},{"issue":"7","key":"4444_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2215\/CJN.01870309","volume":"4","author":"M Sall\u00e9e","year":"2009","unstructured":"Sall\u00e9e M, Rafat C, Zahar J, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4(7):1183\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"4444_CR12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2215\/CJN.06900810","volume":"6","author":"F Jouret","year":"2011","unstructured":"Jouret F, Lhommel R, Beguin C, et al. Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6(7):1644\u201350.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4444_CR13","first-page":"163","volume":"41","author":"MJ Hepburn","year":"2003","unstructured":"Hepburn MJ, Pennick GJ, Sutton DA, et al. Candida krusei renal cyst infection and measurement of amphotericin B levels in cystic fluid in a patient receiving AmBisome. Med Mycol. 2003;41(2):163\u20135.","journal-title":"Med Mycol"},{"issue":"1","key":"4444_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/JCM.41.1.479-482.2003","volume":"41","author":"AA Padhye","year":"2003","unstructured":"Padhye AA, Verghese S, Ravichandran P, et al. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol. 2003;41(1):479\u201382.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4444_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmi.2015.09.024","volume":"22","author":"M Bobot","year":"2016","unstructured":"Bobot M, Ghez C, Gondouin B, et al. Diagnostic performance of [18F] fluorodeoxyglucose positron emission tomography \u2013 computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Microbiol Infect. 2016;22(1):71\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"4444_CR16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrneph.2017.127","volume":"13","author":"MB Lanktree","year":"2017","unstructured":"Lanktree MB, Chapman AB. New treatment paradigms for ADPKD: moving towards precision medicine. Nat Rev Nephrol. 2017;13(12):750\u201368.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"4444_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000446664","volume":"134","author":"MA Lantinga","year":"2016","unstructured":"Lantinga MA, Darding AJM, de S\u00e9vaux RGL, et al. International multi-specialty Delphi survey: identification of diagnostic criteria for hepatic and renal cyst infection. Nephron. 2016;134(4):205\u201314.","journal-title":"Nephron"},{"issue":"1","key":"4444_CR18","first-page":"CD004920","volume":"16","author":"A Cortegiani","year":"2016","unstructured":"Cortegiani A, Russotto V, Maggiore A, et al. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev. 2016;16(1):CD004920.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"4444_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","volume":"3","author":"P Eggimann","year":"2003","unstructured":"Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3(11):685\u2013702.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"4444_CR20","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","volume":"17","author":"AL Colombo","year":"2017","unstructured":"Colombo AL, de Almeida J\u00fanior JN, Slavin MA, et al. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis. 2017;17(11):e344\u201356.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"4444_CR21","first-page":"986","volume":"91","author":"G Chamilos","year":"2006","unstructured":"Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006;91(7):986\u20139.","journal-title":"Haematologica"},{"issue":"6","key":"4444_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy381","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology Laboratory for Diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1\u2013e94.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4444_CR23","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/cid\/cis200","volume":"54","author":"MH Nguyen","year":"2012","unstructured":"Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, \u03b2-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis. 2012;54(9):1240\u20138.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4444_CR24","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1128\/JCM.01737-13","volume":"51","author":"ES Theel","year":"2013","unstructured":"Theel ES, Doern CD. \u03b2-D-glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol. 2013;51(11):3478\u201383.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4444_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1523-1755.2001.00802.x","volume":"60","author":"H Kanda","year":"2001","unstructured":"Kanda H, Kubo K, Hamasaki K, et al. Influence of various hemodialysis membranes on the plasma (1-->3)-beta-D-glucan level. Kidney Int. 2001;60(1):319\u201323.","journal-title":"Kidney Int"},{"issue":"6","key":"4444_CR26","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1128\/JCM.00409-07","volume":"45","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ, Gibbs D, et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol. 2007;45(6):1735\u201345.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4444_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.riam.2013.02.003","volume":"30","author":"AS Mattei","year":"2013","unstructured":"Mattei AS, Alves SH, Mario DA, et al. Susceptibility of Candida albicans blood isolates to 3 antifungal drugs: retrospective study in Rio Grande do Sul, Brazil, 1999-2009. Rev Iberoam Micol. 2013;30(4):243\u20137.","journal-title":"Rev Iberoam Micol"},{"issue":"1","key":"4444_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.idc.2013.09.004","volume":"28","author":"CA Kauffman","year":"2014","unstructured":"Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin N Am. 2014;28(1):61\u201374.","journal-title":"Infect Dis Clin N Am"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4444-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:11:46Z","timestamp":1603843906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4444-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4444"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4444-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent to publish this information was obtained from study participants or their relatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"911"}}